The Food and Drug Administration (FDA) has approved Medtronic’s MiniMed 670G. This is a standard medical device that’s designed to monitor a diabetes patient’s sugar levels, and it automatically injects the needed dose of insulin.
MiniMed 670G comes as the first of its kind as it’s the first insulin delivery system that’s completely automated, and it has been seen as a safe choice for patients. The FDA has approved this insulin pump for people over the age of 14 who have type 1 diabetes; so, for millions of Americans who are suffering from this health condition, this will come as a huge relief.
To know the importance of this insulin pump, we need to know why it’s needed. People with type 1 diabetes do not have enough insulin, and the production of insulin is not possible. Without enough insulin, or the production of the required level of insulin, the glucose and sugar level in our blood would not be regulated, that’s why they are required to regularly replenish their insulin stock, either with daily injections or by using a tiny catheter to pump insulin.